https://www.selleckchem.com/pr....oducts/17-AAG(Geldan
This study aimed to gather a range of opinions, including those of affected people (consumers, concerned others) to identify clinical research priorities for methamphetamine and emerging drugs of concern in Australia, to guide the work of the National Centre for Clinical Research on Emerging Drugs (NCCRED). A priority setting study was conducted (February-March 2019) in four phases online stakeholder survey, thematic analysis of responses, rapid literature review, expert panel ranking of priorities against predetermined cri